LadRx Corporation

About LadRx Corporation

LadRx Corporation is a biopharmaceutical company dedicated to the discovery and development of new therapeutics to address high unmet medical needs for patients.

Products & Services

Arimoclomol:A therapeutic focused on neurodegenerative conditions.

Aldoxorubicin:A treatment developed for oncology applications.

LADR™:A platform or therapeutic technology related to drug development.

Specialties

Neurodegenerative therapeutics Oncology treatments Drug development platforms

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Non-Dilutive Financing T: - FT: Non-Dilutive Financing	A: 11000000 MR: - FA: up to $11 million FAN: 11000000	D: 2023-06-22 FD: 2023-06-22	1 investors

Non-Dilutive Financing Latest

2023-06-22

$11.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jennifer K. Simpson

Chairperson of the Board

J

Joel K. Caldwell

Chairman of the Audit Committee

C

Cary J. Claiborne

Chairman of the Compensation Committee

S

Stephen Snowdy

Chief Executive Officer

J

John Y. Caloz

Chief Financial Officer and Senior Vice President

View 2 more team members with Pro

Unlock Full Team Directory

Recent News